Radius, maker of bone and cancer drugs, to be bought in take-private deal
Bio Pharma Dive
JUNE 23, 2022
Two investment firms, Gurnet Point Capital and Patient Square Capital, have agreed to pay as much as $890 million for Radius, which has come under pressure amid share price declines.
Let's personalize your content